Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
US Market
Holding OBIO?
Track your performance easily

Orchestra BioMed Holdings (OBIO) Cash flow

56 Followers

Orchestra BioMed Holdings Cash Flow

OBIO's free cash flow for Q2 2024 was $-10.31M. For the 2024 fiscal year, OBIO's free cash flow was decreased by $-16.32M and operating cash flow was $-10.21M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -44.58M$ -46.13M$ -29.29M$ -272.36K$ -258.51K
Investing Cash Flow
$ 62.38M$ 10.69M$ -64.12M-$ -160.00M
Financing Cash Flow
$ -10.50M$ 46.22M$ 103.26M-$ 162.29M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 96.67M$ 30.56M$ 19.78M$ 1.75M$ 2.03M
Income Tax Paid Supplemental Data
-----
Interest Paid Supplemental Data
$ 401.00K$ 1.12M$ 1.37M--
Issuance Of Capital Stock
----$ 166.03M
Issuance Of Debt
$ -10.85M$ -10.85M$ 3.55M--
Repayment Of Debt
$ -10.85M$ -10.85M$ -6.45M--
Free Cash Flow
$ -44.71M$ -46.20M$ -29.88M$ -272.36K$ -258.51K
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Orchestra BioMed Holdings Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis